8th Annual TIL Therapies Summit

8th Annual TIL Therapies Summit is organized by Hanson Wade and will be held from Nov 17 - 19, 2026 at Hyatt Regency Boston Harbor, Boston, Massachusetts, United States of America.

Description:
Expand Patient Access in Solid Tumors with Next?Generation TIL, Gene Editing, Harmonized Potency & QC Frameworks to Scale Clinical Studies to Commercial Success

With the first TIL Therapy now approved in both the US and Canada, and the field regrouping following a setback in Europe, this is a pivotal time for drug developers looking to address treatment-resistant solid tumors.

Returning for its 8th year, the TIL Therapies Summit remains the go-to forum for this close-knit community, created with the mission to transform end-to-end TIL development and deliver best-in-class therapies to treat solid tumor indications with significant unmet needs.

With more patients being treated than ever, this summit unites a global collective of biopharma, academic thought leaders and clinicians including Curacell, Junecell, Obsidian Therapeutics, AgonOx, as they share their cutting-edge research into engineered TIL, easier manufacturing, QC, Potency, clinical updates, regulatory updates, investment opportunities and more.